In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7-Reference-Cited by-同舟云学术

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7

Published:2015-03-15 Issue:5 Volume:30 Page:662-670
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Adanyeguh Isaac M.¹,Henry Pierre-Gilles²,Nguyen Tra M.¹,Rinaldi Daisy¹,Jauffret Celine¹,Valabregue Romain³,Emir Uzay E.²,Deelchand Dinesh K.²,Brice Alexis¹,Eberly Lynn E.⁴,Öz Gülin²,Durr Alexandra¹⁵,Mochel Fanny¹⁵

Affiliation:

1. INSERM U 1127, Sorbonne Universités, UPMC Univ Paris Institut du Cerveau et de la Moelle épinière, ICM; Paris France

2. Center for Magnetic Resonance Research, University of Minnesota; Minneapolis MN United States

3. Center for NeuroImaging Research, Institut du Cerveau et de la Moelle épinière; Paris France

4. Division of Biostatistics; School of Public Health, University of Minnesota; Minneapolis MN USA

5. Assistance Publique-Hôpitaux de Paris, Fédération de Génétique, La Pitié-Salpêtrière University Hospital; Paris France

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference41 articles.

1. CAG repeat disorder models and human neuropathology: similarities and differences;Yamada;Acta Neuropathol,2008

2. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data;Jacobi;Lancet Neurol,2013

3. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond;Durr;Lancet Neurol,2010

4. Scale for the assessment and rating of ataxia: development of a new clinical scale;Schmitz-Hübsch;Neurology,2006

5. Ataxia rating scales: psychometric profiles, natural history and their application in clinical trials;Saute;Cerebellum,2012

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal MRI and 1H-MRS study of SCA7 mouse forebrain reveals progressive multiregional atrophy and early brain metabolite changes indicating early neuronal and glial dysfunction;PLOS ONE;2024-01-16

2. Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3;Disease Models & Mechanisms;2023-09-01

3. Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice;Annals of Neurology;2023-08-02

4. MR Imaging in Ataxias: Consensus Recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers;The Cerebellum;2023-06-06

5. Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse model;2023-03-01